NCT01645839 - Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 30, 2011

Primary Completion Date

August 31, 2018

Study Completion Date

March 1, 2019

Conditions

Breast CancerLeptomeningeal Metastases

Interventions

DRUG

Liposomal Cytarabine

50mg (5 mL) by slow intrathecal injection (1-5 minutes) directly into the cerebrospinal fluid (CSF) via a ventricular catheter directly into the lumbar sac during a lumbar puncture.

Trial Locations (10)

21079

Centre G.F. Leclerc, Dijon

34298

Centre Val d'Aurelle, Montpellier

38042

CHU de Grenoble, Grenoble

56100

Centre Hospitalier Bretagne Sud, Lorient

59020

Centre Oscar Lambret, Lille

69677

Centre Hospitalier Universitaire Lyon, Bron

75013

Hôpital Salpétrière, Paris

80054

Centre Hospitalier Universitaire Groupe Sud, Amiens

06002

Centre Hospitalier Universitaire de Nice, Nice

06189

Centre Antoine Lacassagne, Nice

All Listed Sponsors

lead

Centre Oscar Lambret

OTHER